SEMA3B and neoplasm: SEMA3B was first described as a negative mediator of neuronal guidance by binding to neuropilin receptors, and it has been extensively studied as a tumor suppressor protein in various tumors, including lung and breast carcinoma, through the activation of apoptosis and inhibition of migration and tumor cell growth (12, 13).